DUARTE, Calif., Feb. 25, 2025 /PRNewswire/ — Prolacta Bioscience, the world’s leading hospital provider of 100% human milk-based nutritional products, today announced the U.S. Food and Drug ...
Term Infants Fed Human Milk-Based Fortifier Achieved Full Enteral Feeds 30 Days Sooner and Experienced Better Weight Gain Compared to Infants Fed Cow Milk-Based Fortifier DUARTE, Calif., May 15, 2024 ...
Infection is another complication associated with gastroschisis defects. Initially, the newborn is at risk for infection because of the breach in skin integrity from the exteriorized bowel. The risk ...
Results of an investigation conducted by University of Nevada, Reno researchers, public health officials and area physicians published this week in the Archives of Pediatrics & Adolescent Medicine, ...
Washoe County, Nevada, U.S., experienced a cluster of a particular birth defect, gastroschisis, during the period April 2007 - April 2008. Gastroschisis is a birth defect that occurs early in ...
DUARTE, Calif., July 22, 2025 /PRNewswire/ -- Gastroschisis Awareness Month brings good news for families of the 1 out of every 2,400 newborns in the U.S. diagnosed annually with gastroschisis, 1 a ...
Surgifort(R) Human Milk Fortifier, Developed by Prolacta Bioscience, Is the First Human Milk-Based Nutritional Fortifier Indicated for Term Infants DUARTE, Calif., Feb. 25, 2025 /PRNewswire/ -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results